NFL and Kansas City Chiefs Star Art Still on the Missed Signs of Hereditary Amyloidosis

Value of the Information & Strength of the Argument

The value of this episode lies in its firsthand patient perspective, which is crucial for raising awareness about a rare and often underdiagnosed condition. Art Still’s story illustrates how symptoms can be dismissed and the importance of considering genetic causes. The argumentation is persuasive, relying on personal experience and the emotional impact of the diagnosis. However, it is not a scientific study, and the medical information is presented in a simplified manner. The episode effectively argues for the importance of family health history and genetic testing, but it does not delve into the complexities of genetic counseling or the nuances of variant penetrance.

Scientific Rigor, Source Quality, Title Accuracy

The scientific rigor is moderate. The episode is hosted by a genetic counselor, which lends credibility, and the medical facts mentioned (e.g., prevalence of V122I) are accurate. However, no specific studies or sources are cited within the episode. The title accurately reflects the content. The description provides links to DNAToday.com for resources, but these are not directly referenced in the episode. Overall, the information is reliable but not deeply sourced.

The title accurately reflects the content, focusing on Art Still's experience with hereditary amyloidosis and the missed signs.

8/10

The episode features a personal patient story with expert moderation by a genetic counselor, and includes specific medical information (V122I variant, prevalence in African Americans) that aligns with established medical knowledge. However, it is primarily anecdotal and lacks direct citation of primary sources.

Markers derived by PSI from the transcript: the creator did not define chapters.

• 00:00Introduction to Art Still's career and the mystery of his symptoms.
• 02:00Art discusses the 'no pain, no gain' mentality and how it masked symptoms.
• 05:00Liz shares her perspective on Art's health and the realization that something was wrong.
• 08:00Art describes the 2018 NFL Player Care Foundation evaluation and the warning from doctors.
• 10:00The 2023 evaluation and the detailed family health history that led to genetic testing.
• 12:00Art's brother's heart transplant and nephew's genetic testing are discussed.
• 15:00The couple discusses the V122I variant and its prevalence in African Americans.
• 18:00Art's initial mistrust of healthcare and his experience with medication adherence.
• 20:00The founding of Still 4 Life and their mission to raise awareness.
• 25:00Discussion on the importance of family health history and genetic testing.

• DNA Today Episode #407 — The episode description mentions that resources and related episodes are available under Episode #407 at DNAToday.com.

• Hereditary ATTR amyloidosis — OMIM entry for transthyretin amyloidosis, providing genetic and clinical information.